140 related articles for article (PubMed ID: 36934090)
1. ALYREF mediates RNA m
Xue C; Gu X; Zheng Q; Shi Q; Yuan X; Su Y; Jia J; Jiang J; Lu J; Li L
Signal Transduct Target Ther; 2023 Mar; 8(1):130. PubMed ID: 36934090
[No Abstract] [Full Text] [Related]
2. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pSTAT3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract][Full Text] [Related]
3. Roles of circular RNAs in the progression of hepatocellular carcinoma and their values as diagnostic and prognostic biomarkers.
Zhu J; Li J; Wei Y; Wang J; Zhang XY
Gene; 2021 Jan; 767():145175. PubMed ID: 33002570
[No Abstract] [Full Text] [Related]
4. [A study on the methylation of RIZ1 in hepatocellular carcinomas].
Zhang CJ; Li XM; Liu ZS; Zhou GY; Li H; Ma C; Sun YL
Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):631. PubMed ID: 15504302
[No Abstract] [Full Text] [Related]
5. Circular RNA circ‑CCT3 promotes hepatocellular carcinoma progression by regulating the miR‑1287‑5p/TEAD1/PTCH1/LOX axis.
Lin W; Zhang T; Ding G; Hao L; Zhang B; Yu J; Pang Y; Geng F; Zhan L; Zhou M; Yan Q; Wang Y; Zheng C; Li H
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760147
[TBL] [Abstract][Full Text] [Related]
6. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma.
Ninomiya T; Hayashi Y; Saijoh K; Ohta K; Yoon S; Nakabayashi H; Tamaoki T; Kasuga M; Itoh H
J Hepatol; 1996 Oct; 25(4):445-53. PubMed ID: 8912143
[TBL] [Abstract][Full Text] [Related]
7. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway.
Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R
Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531
[TBL] [Abstract][Full Text] [Related]
8. Multiple m
Qu N; Qin S; Zhang X; Bo X; Liu Z; Tan C; Wen G; Jiang H
BMC Cancer; 2020 Feb; 20(1):165. PubMed ID: 32111180
[TBL] [Abstract][Full Text] [Related]
9. An alternative POLDIP3 transcript promotes hepatocellular carcinoma progression.
Liu XN; Yuan JH; Wang TT; Pan W; Sun SH
Biomed Pharmacother; 2017 May; 89():276-283. PubMed ID: 28236701
[TBL] [Abstract][Full Text] [Related]
10. Role of RBM3 in the regulation of cell proliferation in hepatocellular carcinoma.
Miao X; Zhang N
Exp Mol Pathol; 2020 Dec; 117():104546. PubMed ID: 32976820
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma reduces ATXN7L3 to evade estrogen-dependent growth suppression.
Bean J; Mohan RD
EBioMedicine; 2021 Jan; 63():103179. PubMed ID: 33340995
[No Abstract] [Full Text] [Related]
12. Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis.
Kido T; Tabatabai ZL; Chen X; Lau YC
Cancer Sci; 2020 Aug; 111(8):2987-2999. PubMed ID: 32473614
[TBL] [Abstract][Full Text] [Related]
13. ALYREF mainly binds to the 5' and the 3' regions of the mRNA in vivo.
Shi M; Zhang H; Wu X; He Z; Wang L; Yin S; Tian B; Li G; Cheng H
Nucleic Acids Res; 2017 Sep; 45(16):9640-9653. PubMed ID: 28934468
[TBL] [Abstract][Full Text] [Related]
14. Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies.
Bai H; Gayyed MF; Lam-Himlin DM; Klein AP; Nayar SK; Xu Y; Khan M; Argani P; Pan D; Anders RA
Hum Pathol; 2012 Sep; 43(9):1376-85. PubMed ID: 22436626
[TBL] [Abstract][Full Text] [Related]
15. microRNA-608 inhibits human hepatocellular carcinoma cell proliferation via targeting the BET family protein BRD4.
He L; Meng D; Zhang SH; Zhang Y; Deng Z; Kong LB
Biochem Biophys Res Commun; 2018 Jul; 501(4):1060-1067. PubMed ID: 29777702
[TBL] [Abstract][Full Text] [Related]
16. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming.
Liu Y; Ren H; Zhou Y; Shang L; Zhang Y; Yang F; Shi X
J Exp Clin Cancer Res; 2019 May; 38(1):228. PubMed ID: 31142342
[TBL] [Abstract][Full Text] [Related]
17. MiR-590-3p suppresses hepatocellular carcinoma growth by targeting TEAD1.
Ge X; Gong L
Tumour Biol; 2017 Mar; 39(3):1010428317695947. PubMed ID: 28349829
[TBL] [Abstract][Full Text] [Related]
18. USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638.
Ni W; Lin S; Bian S; Zheng W; Qu L; Fan Y; Lu C; Xiao M; Zhou P
Cell Death Dis; 2020 Oct; 11(10):843. PubMed ID: 33040080
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal:The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1.
Chen Z; Liu Y; Yao L; Guo S; Gao Y; Zhu P
J Biol Chem; 2018 May; 293(21):7982-7992. PubMed ID: 29588366
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
